Simple Blood Test for Early Diagnosis of Alzheimer’s Disease Introduced by Australia NSW

Blood-TestAs reported by the Alzheimer’s Australia NSW north coast Regional Manager Gary Thomas, the Port Macquarie electorate in Australia is known to have around 1600 people every week being detected from Alzheimer’s disease and it has been predicted that if a harsh and effective step is not taken to stop this increasing number then in coming years it will just cross its boundaries to devastate the entire health system here. Across Australia, the federal seat of Lyne in known for having the maximum occurrence of dementia in the country.

In order to fight back, a team of researchers from the University of Newcastle has introduced a simple blood test which according to them will help in diagnosing this disease on a pretty early stage. Even before the occurrence of its symptoms, doctors by performing this blood test will be able to judge out the prevalence of Alzheimer. All over the world, the main reason behind the pervasiveness of dementia is the Alzheimer’s disease. In fact it accounts for up to 70% of such cases.

According to Gary Thomas, an early detection of Alzheimer’s disease will definitely help them in introducing several risk-reduction strategies to the affected people, and this will further enable them to bring a drastic improvement in their quality of life.

In order to conduct this study, a research team of 4 members spent a whole one year in reviewing the most wide-ranging collection of Alzheimer’s data in the world. And they revealed out such a way of diagnosing Alzheimer, which according to them was one of the most significant techniques.

Due to Alzheimer’s disease, the brain gets affected and it results in impaired memory, thinking and behavior.

As said by Thomas, “Currently, Alzheimer’s disease diagnosis is based on clinical observations and testing of cognitive capacity and memory loss. Our study makes a considerable step towards cheap, non-invasive testing by identifying a blood protein panel to predict Alzheimer’s disease in its early stages”.